SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
NVCN
--
0.00%
--
How Much Is Neovasc Inc. (TSE:NVCN) CEO Getting Paid?
Simply Wall St. · 3d ago
Will Neovasc (NVCN) Report Negative Q2 Earnings? What You Should Know
Zacks · 4d ago
Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper
Newsfile · 07/24 14:57
Neovasc Reports Its Reducer System Featured In Supplement In Germany's Second Largest National Newspaper, 'Frankfurter Allgemeine Zeitung'
Neovasc, Inc. (“Neovasc” or the “Company”) ((NASDAQ, TSX:NVCN) announced today that the Neovasc Reducer™ (the “Reducer”) was featured in a supplement titled:
Benzinga · 07/24 13:51
Neovsac partially prepays convertible debenture
Seeking Alpha - Article · 07/23 21:42
Neovasc Announces Partial Prepayment of Convertible Debenture
Newsfile · 07/23 21:23
Neovasc Announces Partial Prepayment Of Convertible Debenture
VANCOUVER and MINNEAPOLIS, July 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. (“Neovasc” or the “Company”) ((NASDAQ, TSX:NVCN) announced today that Strul Medical Group LLC
Benzinga · 07/23 20:20
FDA Ad Com set for Neovasc Reducer device
Seeking Alpha - Article · 07/09 13:04
Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer(TM) Device
Newsfile · 07/09 12:30
Neovasc Reports FDA Circulatory System Devices Panel Will Review Premarket Approval Application For Neovasc Reducer Device At Oct. 27, 2020 Meeting
 Neovasc, Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company"), announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the Circulatory System
Benzinga · 07/09 11:36
Neovasc reports Q2 preliminary revenue
Neovasc (NASDAQ:NVCN) +0.8% reports Q2 preliminary revenue of ~$295,000 down from $440,420K due to a reduction in reducer procedures that began in mid-Marc
seekingalpha · 07/06 18:41
Neovasc Provides Update on Second Quarter Results
Newsfile · 07/06 14:25
Neovasc reports Q2 preliminary revenue
Seeking Alpha - Article · 07/06 13:41
Neovasc Sees Q2 Sales About $295K; Co. Says 'Revenues were negatively impacted by a reduction in Reducer procedures that began in mid-March and persisted through early June,' Co. To Report Full Results Aug. 6
Benzinga · 07/06 13:32
Neovasc Reducer(TM) and Tiara(TM) Featured at Leading Industry Virtual Conferences
Newsfile · 06/29 17:00
Neovasc Reducer And Tiara Featured At Leading Industry Virtual Conferences
Neovasc Reducer™ and Tiara™ Featured at Leading Industry Virtual Conferences VANCOUVER and MINNEAPOLIS, MN, June 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --Neovasc, Inc.("Neovasc" or the
Benzinga · 06/29 16:02
Neovasc 13G Filing From Strul Medical Group Shows 9.99% Stake
Benzinga · 06/29 15:23
Neovasc Reducer shows treatment benefit in observational study
Seeking Alpha - Article · 06/26 14:49
Neovasc Announces Positive Interim Results from REDUCER-I Study
Newsfile · 06/26 14:45
Neovasc Announces Positive Interim Results From REDUCER-I Study; 70% Of Patients Saw Improvement In Symptoms By At Least 1CCS Class That Was Maintained Through 3 Years
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - June 26, 2020) - Neovasc Inc. (NASDAQ:NVCN) (TSX:NVCN) ("Neovasc" or the "Company") today announced positive interim
Benzinga · 06/26 13:47